Steven Barth Discusses Regulatory Hurdles for Strategic Buyers
15 October 2024
S&P Global
Foley & Lardner LLP partner Steven Barth commented on the regulatory hurdles strategic buyers face in the S&P Global article, “Private equity fuels TMT M&A for 2nd consecutive quarter in Q3.”
“We live in a current regulatory environment where we can no longer provide reliable advance advice to our clients about whether a deal will likely receive regulatory approval,” Barth explained, highlighting that consequentially, transactional attorneys are emphasizing caution when advising clients.
“We like to be right. And on deals that never get submitted for approval, we’re always right,” Barth added.
Barth’s commentary also appeared in the S&P Global article, “Private equity deals regain momentum; buyout shops lead TMT sector M&A.”
People
Related News
27 November 2024
In the News
Lawrence Kraus Describes Loper Bright's Impact on False Claims Cases
Foley & Lardner LLP partner Lawrence Kraus is quoted in the Relias Media article, "Loper Bright Starting to Affect False Claims Cases."
26 November 2024
In the News
David Rosen on FDA GLP-1 Legal Battle – 'It's a precedent in this area'
Foley & Lardner LLP partner David Rosen described the legal battle between compounding pharmacies and the U.S. Food and Drug Administration over GLP-1 drugs in the BioSpace article, "Legal Challenge Over Lilly’s GLP-1 Shortages Highlights FDA’s Post-Chevron Vulnerability."
26 November 2024
In the News
Sara Abarbanel and Jacqueline Hayduk Assess Best Practices for Employee Assistance Programs
Employee assistance programs have become an extremely common benefit offered by U.S. employers.